Home » Topics » BioWorld Science

BioWorld Science
RSS

Potential target for a malaria vaccine identified

Jan. 21, 1998

PDMP analogues studied for malaria inhibition

Jan. 21, 1998

Novel coronary artery disease gene therapy scheduled to enter clinical trials

Jan. 21, 1998

Pharmacological profile of broad-spectrum, nonopioid analgesic described by Abbott

Jan. 21, 1998

Novel antitumor cyanoguanidines with good oral bioavailability

Jan. 21, 1998

New chelating agent developed by Israeli researchers

Jan. 21, 1998

Hemodynamic profile of new K+ channel activator

Jan. 21, 1998

Selective inhibitor of PDGF receptor autophosphorylation from Kirin Brewery

Jan. 21, 1998

Antiprogestational agents with reduced antiglucocorticoid activity claimed by HHS

Jan. 21, 1998

Duphar presents new vitamin D analogues

Jan. 21, 1998

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...